AHCO vs. ADUS, BTSG, EHAB, AVAH, AMED, LGND, GMTX, ALHC, PHR, and IRWD
Should you be buying AdaptHealth stock or one of its competitors? The main competitors of AdaptHealth include Addus HomeCare (ADUS), BrightSpring Health Services (BTSG), Enhabit (EHAB), Aveanna Healthcare (AVAH), Amedisys (AMED), Ligand Pharmaceuticals (LGND), Gemini Therapeutics (GMTX), Alignment Healthcare (ALHC), Phreesia (PHR), and Ironwood Pharmaceuticals (IRWD). These companies are all part of the "medical" sector.
AdaptHealth (NASDAQ:AHCO) and Addus HomeCare (NASDAQ:ADUS) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, community ranking, earnings, profitability, institutional ownership, dividends and risk.
AdaptHealth has a beta of 1.06, suggesting that its share price is 6% more volatile than the S&P 500. Comparatively, Addus HomeCare has a beta of 0.96, suggesting that its share price is 4% less volatile than the S&P 500.
Addus HomeCare has lower revenue, but higher earnings than AdaptHealth. AdaptHealth is trading at a lower price-to-earnings ratio than Addus HomeCare, indicating that it is currently the more affordable of the two stocks.
Addus HomeCare has a net margin of 5.91% compared to AdaptHealth's net margin of -21.21%. Addus HomeCare's return on equity of 9.70% beat AdaptHealth's return on equity.
82.7% of AdaptHealth shares are owned by institutional investors. Comparatively, 95.4% of Addus HomeCare shares are owned by institutional investors. 13.6% of AdaptHealth shares are owned by company insiders. Comparatively, 4.6% of Addus HomeCare shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Addus HomeCare received 220 more outperform votes than AdaptHealth when rated by MarketBeat users. Likewise, 66.97% of users gave Addus HomeCare an outperform vote while only 58.91% of users gave AdaptHealth an outperform vote.
AdaptHealth currently has a consensus target price of $12.26, indicating a potential upside of 26.49%. Addus HomeCare has a consensus target price of $106.57, indicating a potential downside of 0.48%. Given AdaptHealth's higher probable upside, equities research analysts plainly believe AdaptHealth is more favorable than Addus HomeCare.
In the previous week, Addus HomeCare had 10 more articles in the media than AdaptHealth. MarketBeat recorded 20 mentions for Addus HomeCare and 10 mentions for AdaptHealth. Addus HomeCare's average media sentiment score of 0.54 beat AdaptHealth's score of -0.21 indicating that Addus HomeCare is being referred to more favorably in the news media.
Summary
Addus HomeCare beats AdaptHealth on 14 of the 18 factors compared between the two stocks.
Get AdaptHealth News Delivered to You Automatically
Sign up to receive the latest news and ratings for AHCO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AHCO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
AdaptHealth Competitors List
Related Companies and Tools
